This exciting new programme has been introduced as a spin-off from the very successful Drug Discovery MSc in response to the increasing opportunities which now exist for research scientists who can evaluate the business potential of their science as well as generate the science itself.
Modes and duration
Tuition fees (2017/18)
- £12,950 (FT)
- £25,130 (FT)
Note on fees: The tuition fees shown are for the year indicated above. Fees for subsequent years may increase or otherwise vary. Further information on fee status, fee increases and the fee schedule can be viewed on the UCL Current Students website.
A second-class UK Bachelor’s degree or higher in a related subject such as pharmacy, pharmaceutical science, pharmacology, physiology, physical science, biochemistry, biotechnology, chemistry, chemical engineering, genetics, material sciences, or a medical degree (MBBS), or an overseas qualification of an equivalent standard.
English language requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Good
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
About this degree
This MSc contains the science core of the Drug Discovery MSc and combines a broad overview of the drug discovery and development process with specialisation in management training and awareness, and strategic partnering and business development skills.
Students undertake modules to the value of 180 credits.
The programme consists of four core modules (120 credits), and a dissertation (60 credits).
- The Process of Drug Discovery
- The Process of Drug Development
- Modern Aspects of Drug Discovery
- Pharma Management
- There are no optional modules for this programme.
All students undertake a business development project based on an aspect of science from drug discovery either at the UCL School of Pharmacy or in industry.
Teaching and learning
The programme is delivered through a combination of lectures, tutorials and seminars and practical classes. Assessment is through a combination of written examination and coursework. The business development project is by written report and oral presentation to the class and a judging panel of scientists and managers.
For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
Students who complete the Drug Discovery and Pharma Management MSc will progress to careers in the varous aspects of the pharmaceutical and biotechnology industries including research, product development and manufacturing, clinical trials and regulatory affairs.
Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2012–2014 graduating cohorts six months after graduation.
Why study this degree at UCL?
The Pharma Management component of this MSc is led by Dr Nigel Ratcliffe, formerly Vice-President for regulatory and commercial affairs at Astra Zeneca.
Students visit a leading research laboratory e.g. GlaxoSmithKline to look at computer-based molecular modelling, how physico-chemical properties are determined, the robotic compound library, and high throughput screening. The visit is supplemented by material and instruction and the discovery process of a drug will be worked through in detail.
Students attend a one-day research conference on an aspect of drug discovery and development organised by the Society for Medicines Research where there is opportunity to interact with leading industrialists and researchers in the field.
Department: School of Pharmacy
Student / staff numbers
› 99 staff
including 42 postdocs
› 148 taught students
› 133 research students
Staff/student numbers information correct as of 1 August 2017.
Research Excellence Framework (REF)
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: School of Pharmacy
76% rated 4* (world-leading) or 3* (internationally excellent)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
Who can apply?
This programme is designed for graduates in science-based subjects who wish to combine a career in the pharmaceutical or biotechnology industry with a management or business development role
- All applicants
- 29 August 2017
For more information see our Applications page.Apply now
What are we looking for?
When we assess your application we would like to learn:
- how your academic and professional background meets the demands of Drug Discovery and Pharma Management
- why you want to study Drug Discovery and Pharma Management at graduate level
- what particularly attracts you to this programme at the UCL School of Pharmacy
- where you would like to go professionally with your degree and how this programme meets these needs
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.
- Dr Michael Munday